1. Home
  2. PROV vs VRCA Comparison

PROV vs VRCA Comparison

Compare PROV & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Provident Financial Holdings Inc.

PROV

Provident Financial Holdings Inc.

HOLD

Current Price

$17.16

Market Cap

103.7M

Sector

Finance

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.40

Market Cap

87.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROV
VRCA
Founded
1956
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.7M
87.5M
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
PROV
VRCA
Price
$17.16
$6.40
Analyst Decision
Hold
Buy
Analyst Count
2
2
Target Price
$16.25
$17.00
AVG Volume (30 Days)
7.8K
70.2K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
N/A
$35,577,000.00
Revenue This Year
$4.14
N/A
Revenue Next Year
$3.70
$94.44
P/E Ratio
$36.51
N/A
Revenue Growth
N/A
370.22
52 Week Low
$14.85
$0.39
52 Week High
$17.42
$9.82

Technical Indicators

Market Signals
Indicator
PROV
VRCA
Relative Strength Index (RSI) 68.77 54.19
Support Level $15.63 $5.16
Resistance Level $17.35 $6.40
Average True Range (ATR) 0.22 0.45
MACD -0.02 -0.01
Stochastic Oscillator 50.00 42.55

Price Performance

Historical Comparison
PROV
VRCA

About PROV Provident Financial Holdings Inc.

Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. It is a financial services company committed to serving consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its business activities consist of community banking, investment services and trustee services for real estate transactions. The group operates in Bank segment that include attracting deposits, offering banking services and originating and purchasing single-family, multi-family, commercial real estate, construction and, to a lesser extent, other mortgage, commercial business and consumer loans. Its evenues are derived from interest earned on its loan and investment portfolios, and fees generated through its community banking activities.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Share on Social Networks: